Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes

Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes

Recent studies suggest a pathogenetic association between metabolic disturbances, including type 2 diabetes (T2DM), and cognitive decline and indicate that T2DM may represent a risk factor for Alzheimer’s disease (AD). There are a number of experimental studies presenting evidence that ranolazine, a...

Full description

Bibliographic Details
Main Authors: Velia Cassano, Martina Tallarico, Giuseppe Armentaro, Caterina De Sarro, Michelangelo Iannone, Antonio Leo, Rita Citraro, Emilio Russo, Giovambattista De Sarro, Marta Letizia Hribal, Angela Sciacqua
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
Alzheimer’s
neurodegeneration
ranolazine
type 2 diabetes mellitus
Online Access:https://www.mdpi.com/1422-0067/23/24/16160

Internet

https://www.mdpi.com/1422-0067/23/24/16160

Similar Items